Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21481790rdf:typepubmed:Citationlld:pubmed
pubmed-article:21481790lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:21481790lifeskim:mentionsumls-concept:C0029016lld:lifeskim
pubmed-article:21481790lifeskim:mentionsumls-concept:C1384616lld:lifeskim
pubmed-article:21481790lifeskim:mentionsumls-concept:C0023449lld:lifeskim
pubmed-article:21481790lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:21481790lifeskim:mentionsumls-concept:C0017428lld:lifeskim
pubmed-article:21481790lifeskim:mentionsumls-concept:C1417102lld:lifeskim
pubmed-article:21481790lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:21481790lifeskim:mentionsumls-concept:C1519595lld:lifeskim
pubmed-article:21481790pubmed:issue4lld:pubmed
pubmed-article:21481790pubmed:dateCreated2011-4-12lld:pubmed
pubmed-article:21481790pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:abstractTextTo identify oncogenic pathways in T cell acute lymphoblastic leukemia (T-ALL), we combined expression profiling of 117 pediatric patient samples and detailed molecular-cytogenetic analyses including the Chromosome Conformation Capture on Chip (4C) method. Two T-ALL subtypes were identified that lacked rearrangements of known oncogenes. One subtype associated with cortical arrest, expression of cell cycle genes, and ectopic NKX2-1 or NKX2-2 expression for which rearrangements were identified. The second subtype associated with immature T cell development and high expression of the MEF2C transcription factor as consequence of rearrangements of MEF2C, transcription factors that target MEF2C, or MEF2C-associated cofactors. We propose NKX2-1, NKX2-2, and MEF2C as T-ALL oncogenes that are activated by various rearrangements.lld:pubmed
pubmed-article:21481790pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:languageenglld:pubmed
pubmed-article:21481790pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:citationSubsetIMlld:pubmed
pubmed-article:21481790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21481790pubmed:statusMEDLINElld:pubmed
pubmed-article:21481790pubmed:monthAprlld:pubmed
pubmed-article:21481790pubmed:issn1878-3686lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:PietersRobRlld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:StaalFrank...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:SoulierJeanJlld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:LangerakAnton...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:MeijerinkJule...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:HorstmannMart...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:FerrandoAdolf...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:VerhaafBrenda...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:BeverlooH...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:SigauxFrancoi...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:CayuelaJean...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:Pike-OverzetK...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:StubbsAndrewAlld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:KlousPetraPlld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:Buijs-Gladdin...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:KooiClarissaClld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:HommingaIrene...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:VerstegenMoni...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:VuerhardMaart...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:21481790pubmed:authorpubmed-author:WiekmeijerAnn...lld:pubmed
pubmed-article:21481790pubmed:copyrightInfoCopyright © 2011 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:21481790pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21481790pubmed:day12lld:pubmed
pubmed-article:21481790pubmed:volume19lld:pubmed
pubmed-article:21481790pubmed:ownerNLMlld:pubmed
pubmed-article:21481790pubmed:authorsCompleteYlld:pubmed
pubmed-article:21481790pubmed:pagination484-97lld:pubmed
pubmed-article:21481790pubmed:dateRevised2011-7-13lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:meshHeadingpubmed-meshheading:21481790...lld:pubmed
pubmed-article:21481790pubmed:year2011lld:pubmed
pubmed-article:21481790pubmed:articleTitleIntegrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.lld:pubmed
pubmed-article:21481790pubmed:affiliationDepartment of Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands.lld:pubmed
pubmed-article:21481790pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21481790pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:4208entrezgene:pubmedpubmed-article:21481790lld:entrezgene
entrez-gene:4821entrezgene:pubmedpubmed-article:21481790lld:entrezgene
entrez-gene:7080entrezgene:pubmedpubmed-article:21481790lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21481790lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21481790lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:21481790lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21481790lld:pubmed